IP Library Granted Patent US 9,992,995
Granted Patent B2
US 9,992,995 · App. 14/487,569 · Granted Jun 12, 2018

Systems and methods for solvent-free delivery of volatile compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,992,995
App. No.
14/487,569
Granted
Jun 12, 2018
Kind
B2
Abstract

Provided are systems and methods for solvent-free delivery of volatile compounds, where an energy source is used to release the volatile compounds. The systems and methods provided herein have at least one advantage of (1) no solvent (for example water) is required; (2) immediate release of volatile compounds (for example 1-MCP can be released from HAIP within milliseconds or seconds instead of minutes or hours of the existing method using water); and/or (3) instantly starting and stopping the delivery of the volatile compound.

Claims (48)

1. A solvent-free system for delivery of a volatile compound, comprising

a molecular complex of the volatile compound and an inclusion complex;

a treatment compartment; and

a means of an energy source,

wherein the solvent-free system is configured to release the volatile compound from the molecular complex without water.

2. The system of claim 1 , further comprising an elastomer.

3. The system of claim 2 , wherein the elastomer comprises ethylene vinyl acetate.

4. The system of claim 1 , wherein the volatile compound comprises a cyclopropene.

5. The system of claim 4 , wherein the cyclopropene is of the formula:

wherein R is a substituted or unsubstituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, phenyl, or naphthyl group; wherein the substituents are independently halogen, alkoxy, or substituted or unsubstituted phenoxy.

6. The system of claim 5 , wherein R is C 1 -C 8 alkyl.

7. The system of claim 5 , wherein R is methyl.

8. The system of claim 4 , wherein the cyclopropene is of the formula:

wherein R 1 is a substituted or unsubstituted C 1 -C 4 alkyl, C 1 -C 4 alkenyl, C 1 -C 4 alkynyl, C 1 -C 4 cycloalkyl, cycloalkylalkyl, phenyl, or naphthyl group; and R 2 , R 3 , and R 4 are hydrogen.

9. The system of claim 4 , wherein the cyclopropene is 1-methylcyclopropene (1-MCP).

10. The system of claim 1 , wherein the inclusion complex comprises an agent selected from the group consisting of substituted cyclodextrins, unsubstituted cyclodextrins, crown ethers, zeolites, and combinations thereof.

11. The system of claim 1 , wherein the inclusion complex comprises a cyclodextrin.

12. The system of claim 11 , wherein the cyclodextrin is selected from the group consisting of alpha-cyclodextrin, beta-cyclodextrin, gamma-cyclodextrin, and combinations thereof.

13. The system of claim 1 , wherein the treatment compartment is selected from the group consisting of a thermal desorption tube, a glass bottle, a Tedlar bag, an aluminum cup, and combinations thereof.

14. The system of claim 1 , wherein the energy source comprises at least one of electrical energy, magnetic energy, electromagnetic energy, ultrasonic energy, acoustic energy, and thermal energy.

15. The system of claim 1 , wherein the energy source comprises at least one energy characteristic of waveform, frequency, amplitude, or duration.

16. The system of claim 1 , wherein the means of the energy source comprises heating to a temperature between 100° C. and 300° C.

17. The system of claim 1 , wherein the means of the energy source comprises heating to a temperature between 150° C. and 250° C.

18. The system of claim 1 , wherein the means of the energy source is performed in an enclosed environment.

19. The system of claim 1 , wherein the means of the energy source is performed in an environment at a temperature between −30° C. and 10° C.

20. The system of claim 1 , wherein the means of the energy source is performed in a cold storage room or cold storage facility.

21. The system of claim 1 , wherein the inclusion complex comprises a molecular encapsulating agent and a cyclopropene.

22. The system of claim 10 , wherein the agent comprises a cavity.

23. The system of claim 22 , wherein the cavity comprises cyclopropene.

24. The system of claim 23 , wherein the cyclopropene is located within the cavity.

25. The system of claim 21 , wherein there are no covalent bonds between the cyclopropene and the molecular encapsulating agent.

26. The system of claim 21 , wherein there are no ionic bonds between the cyclopropene and the molecular encapsulating agent.

27. The system of claim 21 , wherein there is an electrostatic attraction between one or more polar moiety of the cyclopropene and one or more polar moiety of the molecular encapsulating agent.

28. The system of claim 21 , wherein there is no electrostatic attraction between one or more polar moiety of the cyclopropene and one or more polar moiety of the molecular encapsulating agent.

29. The system of claim 21 , wherein the interior of the cavity is substantially apolar, hydrophobic, or both.

30. The system of claim 21 , wherein the cyclopropene is substantially apolar, hydrophobic, or both.

31. The system of claim 30 , wherein the cyclopropene is apolar.

32. The system of claim 31 , wherein van der Waals forces, hydrophobic interactions, or both, keep the cyclopropene within the cavity.

33. The system of claim 21 , wherein the ratio of moles of molecular encapsulating agent to moles of cyclopropene is 0.1 or larger.

34. The system of claim 33 , wherein the ratio of moles of molecular encapsulating agent to moles of cyclopropene is 0.2 or larger.

35. The system of claim 34 , wherein the ratio of moles of molecular encapsulating agent to moles of cyclopropene is 0.5 or larger.

36. The system of claim 35 , wherein the ratio of moles of molecular encapsulating agent to moles of cyclopropene is 0.9 or larger.

37. The system of claim 21 , wherein the ratio of moles of molecular encapsulating agent to moles of cyclopropene is 2 or lower.

38. The system of claim 37 , wherein the ratio of moles of molecular encapsulating agent to moles of cyclopropene is 1.5 or lower.

39. The system of claim 1 , wherein the means of an energy source is selected from the group consisting of conduction, convection, and radiation.

40. The system of claim 39 , wherein the radiation energy source is selected from the group consisting of lasers, microwave, and infrared.

41. The system of claim 39 , wherein the convection energy source is provided by flowing heated gas or flowing heated liquid.

42. The system of claim 39 , wherein the means of an energy source is conduction.

Assignments (7)
AGREEMENT OF AGENT RESIGNATION, APPOINTMENT AND ACCEPTANCE & MASTER ASSIGNMENT OF SECURITY DOCUMENTS Recorded Jun 24, 2024
From: JPMORGAN CHASE BANK, N.A.
To: ALTER DOMUS US LLC
Reel/Frame 067914/0941 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 036243, FRAME 0244 Recorded Apr 3, 2023
From: BANK OF MONTREAL
To: AGROFRESH, INC.
Reel/Frame 063238/0848 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 053316, FRAME 0561 Recorded Apr 3, 2023
From: BANK OF MONTREAL
To: AGROFRESH, INC.
Reel/Frame 063238/0901 →
SECURITY INTEREST Recorded Mar 31, 2023
From: AGROFRESH INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 063214/0683 →
PATENT SECURITY AGREEMENT Recorded Jul 27, 2020
From: AGROFRESH, INC.
To: BANK OF MONTREAL, AS COLLATERAL AGENT
Reel/Frame 053316/0561 →
SECURITY INTEREST Recorded Jul 31, 2015
From: AGROFRESH INC.
To: BANK OF MONTREAL, AS ADMINISTRATIVE AGENT
Reel/Frame 036243/0244 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2014
From: GHOSH, TIRTHANKAR
To: AGROFRESH INC.
Reel/Frame 033919/0245 →